中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月17日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药
  骨科医学 本期目录 | 过刊浏览 | 高级检索 |
冲击波联合Mulligan 技术治疗早中期老年膝骨关节炎的临床观察
卞海萍1 马文虎2 祁晓1 李亚1▲
1.江苏省常州市武进人民医院江苏大学附属武进医院徐州医科大学武进临床学院,江苏常州 213017;
2.江苏省常州市武进人民医院中医骨伤科,江苏常州 213017
Clinical observation of extracorporeal shock wave combined with Mulligan technique in the treatment of early and middle stage elderly knee osteoarthritis
BIAN Haiping1 MA Wenhu2 QI Xiao1 LI Ya1▲
1.The Rehabilition Medicine Department of Changzhou Wujin People's Hospital,Wujin Hospital,affiliated to Jiangsu University,Wujin Clinical College of Xuzhou Medical University,Jiangsu Province,Changzhou 213017,China;
2.Department of Orthopeclics and Traumatology of Tradirional Chinese Medicine,Changzhou Wujin People's Hospital,Jiangsu Province,Changzhou 213017,China
全文: PDF (600 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 
 目的 观察体外冲击波(ESWT)联合Mulligan 技术治疗老年膝骨关节炎(KOA)早中期患者的临床疗效。方法 选取2021 年7 月至2022 年12 月常州市武进人民医院康复医学科收治的96 例老年KOA 患者作为研究对象,采用随机数字表法分为对照组和观察组,每组各48 例。对照组采用体外冲击波治疗KOA 患者患膝,观察组则采用体外冲击波联合Mulligan 技术进行治疗。比较两组治疗前及治疗1 个疗程后视觉模拟评分(VAS)、肿胀评分、膝关节活动度(ROM)、西安大略和麦克马斯特大学(WOMAC)骨关节炎指数量表评分。结果 经治疗1 个疗程后,观察组总有效率高于对照组,差异有统计学意义(P<0.05);观察组治疗1 个疗程后VAS、关节肿胀评分、WOMAC 评分低于对照组,膝关节ROM 高于对照组,差异有统计学意义(P<0.05)。结论 体外冲击波联合Mulligan 技术治疗KOA 早中期患者能更好地改善患者的疼痛和活动度。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 体外冲击波Mulligan 技术膝骨关节炎视觉模拟评分关节活动度西安大略和麦克马斯特大学骨关节炎指数量表评分    
Abstract
Objective To observe the clinical efficacy of extracorporeal shock wave(ESWT)combined with Mulligan technique in the treatment of early to middle stage knee osteoarthritis(KOA)in elderly patients.Methods From July 2021 to December 2022,a total of 96 elderly patients with KOA admitted to the Rehabilitation Medicine Department of Changzhou Wujin People's Hospital were selected as the study objects.They were divided into the control group and the observation group with 48 cases each according to the random number table method.The control group received extracorporeal shock wave therapy,while the observation group received extracorporeal shock wave therapy combined with Mulligan technique.The visual analogue scales (VAS),joint swelling scores,range of motion (ROM),and The Western Ontario and McMaster Universities(WOMAC)osteoarthritis index scores were observed before and after a course of treatment in both groups.Results After one course of treatment,the total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After one course of treatment,the VAS,joint swelling scores,and WOMAC scores in the observation group were lower than those in the control group,and the knee joint ROM was higher than that in the control group,and the differences were statistically significant(P<0.05).Conclusion The combination of extracorporeal shock wave and Mulligan technology can better improve pain and mobility in the early and middle stages of KOA patients.
Key wordsExtracorporeal shock wave therapy    Mulligan technique    Knee osteoarthritis    Visual analogue scale    Range of motion    Western Ontario and McMaster Universities
    
基金资助:江苏省常州市武进区科技计划(社会发展)项目(WS202104)。
引用本文:   
卞海萍; 马文虎; 祁晓; 李亚. 冲击波联合Mulligan 技术治疗早中期老年膝骨关节炎的临床观察[J]. 中国当代医药, 2024, 31(12): 65-69.
BIAN Haiping1 MA Wenhu2 QI Xiao1 LI Ya1▲. Clinical observation of extracorporeal shock wave combined with Mulligan technique in the treatment of early and middle stage elderly knee osteoarthritis. 中国当代医药, 2024, 31(12): 65-69.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2024/V31/I12/65
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载